What is the future of targeted therapy in rheumatology: biologics or small molecules?

dc.contributor.author	Mócsai Attila
dc.contributor.author	Kovács L
dc.contributor.author	Gergely P
dc.date.accessioned	2014-06-24T18:21:45Z
dc.date.available	2014-06-24T18:21:45Z
dc.date.issued	2014
dc.identifier	84897524513
dc.identifier.citation	pagination=Article Number 43; journalVolume=12; journalTitle=BMC MEDICINE;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/228
dc.identifier.uri	doi:10.1186/1741-7015-12-43
dc.relation.ispartof	urn:issn:1741-7015
dc.title	What is the future of targeted therapy in rheumatology: biologics or small molecules?
dc.type	Journal Article
dc.date.updated	2014-06-24T18:21:19Z
dc.language.rfc3066	en
dc.identifier.mtmt	2548052
dc.identifier.wos	000334708500001